Insulin injection errors are essential to recognize and correct at every health encounter. We present an individual who had a medication error related to the dosing administration of his medication pen. This error led to a subtherapeutic response to the treatment of his type 2 diabetes and was not remedied by increasing the dosage or frequency of prescribed insulin to try and obtain efficacy. Case DescriptionA 58-year-old Caucasian male is followed by his primary care team for management of type 2 diabetes mellitus. He was first diagnosed with type 2 diabetes in 2011, and in early 2019, he was being treated with an oral regimen consisting of metformin 2000 mg per day. The individual had been prescribed an insulin glargine pen by another provider in 2014, but the insulin glargine was stopped at an unknown time before 2019.He was followed by a weight management service from 2017 to 2018 but was discharged after small progress was made, and he was no longer interested in bariatric surgery. No diabetes medications were changed or added by the weight management service. None of these providers were still involved with his care.The primary care provider referred the person to a primary care pharmacist in March
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.